Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Spring on the Road
Spring Wellness
Premier Home Stylle Tour 2024
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Merck & Co
(NY:
MRK
)
117.03
-0.20 (-0.17%)
Streaming Delayed Price
Updated: 12:23 PM EDT, Sep 20, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Merck & Co
< Previous
1
2
3
4
5
6
7
8
9
...
73
74
Next >
What's Wrong With Merck's Stock?
September 05, 2024
Is the healthcare stock an underrated buy right now?
Via
The Motley Fool
The Smartest Dividend Stocks to Buy With $5,000 Right Now
September 05, 2024
These stocks have a long history of increasing dividends.
Via
The Motley Fool
Merck's Death Cross Vs. Gilead's Golden Cross: Pharma Giants Diverge On Wall Street
September 03, 2024
Merck flirts with bearish trends; Gilead is on a golden streak. Who wins? Investors should keep an eye on these diverging technical signals.
Via
Benzinga
Despite Medicare Negotiations, Americans May Still Have To Pay More For Prescription Drugs
September 03, 2024
Despite Medicare's first-ever negotiated drug prices under the Inflation Reduction Act, U.S. costs remain significantly higher than those in other wealthy nations, with some prices still more than...
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
10 Health Care Stocks With Whale Alerts In Today's Session
September 03, 2024
Via
Benzinga
(MRK) - Analyzing Merck & Co's Short Interest
September 03, 2024
Via
Benzinga
Behind the Scenes of Merck & Co's Latest Options Trends
August 30, 2024
Via
Benzinga
Uncovering Dividend Opportunities with NYSE:MRK.
August 30, 2024
Why MERCK & CO. INC. (NYSE:MRK) qualifies as a good dividend investing stock.
Via
Chartmill
2 Dividend Stocks You Can Safely Hold Through a Recession
September 02, 2024
These stocks can help you sleep peacefully at night, even in bad times.
Via
The Motley Fool
Moderna And BioNTech Bet On Personalized Cancer Vaccines To Revive Fortunes After Dwindling COVID-19 Vaccine Sales
August 29, 2024
BioNTech and Moderna are advancing personalized cancer vaccines using mRNA technology. Despite promising early results, these innovative treatments face challenges in cost, scalability, and...
Via
Benzinga
Exposures
COVID-19
Merck Pulls Plug On Two Keytruda Late-Stage Studies On Underwhelming Data
August 29, 2024
Merck discontinues two Phase 3 trials, KEYNOTE-867 and KEYNOTE-630, for Keytruda in lung cancer and cutaneous squamous cell carcinoma. Independent committees found no survival benefit and higher...
Via
Benzinga
Dow Jones Industrial Average Pares Recent Gains As Investors Take A Pause
August 28, 2024
The Dow Jones Industrial Average (DJIA) trimmed near-term gains on Wednesday, backsliding 150 points in the midweek market session.
Via
Talk Markets
Topics
Stocks
Exposures
US Equities
12 Dividend Stocks to Earn Income Every Month
August 28, 2024
Get paid a dividend on a monthly basis.
Via
The Motley Fool
Comparing Merck & Co With Industry Competitors In Pharmaceuticals Industry
August 28, 2024
Via
Benzinga
NYSE:MRK is probably undervalued for the fundamentals it is displaying.
August 28, 2024
MERCK & CO. INC. (NYSE:MRK) is a prime example of a stock that offers more than what meets the eye in terms of fundamentals.
Via
Chartmill
Options: An Unlikely Source Of Income
August 27, 2024
Calls give the buyer the right, but not the obligation, to buy a stock at a specific price by a specific date. The seller of the call must deliver the stock if the buyer requests it.
Via
Talk Markets
3 Ways the Democratic Party's Platform Could Impact Biotech and Pharma Stocks if Implemented
August 27, 2024
There's no reason to succumb to gloom and doom here.
Via
The Motley Fool
Merck & Co's Options: A Look at What the Big Money is Thinking
August 26, 2024
Via
Benzinga
Week In Review: Multitude Out-Licenses Tissue Factor ADC To Adcendo In $1 Billion Deal
August 24, 2024
Shanghai Multitude Therapeutics out-licensed global rights for its Tissue Factor ADC to Adcendo in a $1 billion agreement. The value of the agreement includes upfront and milestone payments, with...
Via
Talk Markets
Cancer Medicines From Merck, Bristol Myers And BeiGene In Question, As FDA Committee To Discuss Limiting PD-1 Drugs For Stomach Cancer
August 23, 2024
The FDA's Oncologic Drugs Advisory Committee will meet on September 26 to reevaluate the approvals of checkpoint inhibitors for advanced gastric, gastroesophageal junction adenocarcinoma, and...
Via
Benzinga
Exposures
Product Safety
Merck's Ebola Vaccine Showed 84% Effectiveness During Large Outbreak In Africa
August 22, 2024
Merck's rVSV-ZEBOV vaccine, the only WHO-prequalified vaccine for Ebola outbreaks caused by the Zaire ebolavirus, is FDA-approved for adults and children. A study on the 2018–20 Congo outbreak shows...
Via
Benzinga
Merck & Co's Options: A Look at What the Big Money is Thinking
August 19, 2024
Via
Benzinga
In-Depth Analysis: Merck & Co Versus Competitors In Pharmaceuticals Industry
August 14, 2024
Via
Benzinga
Big Pharma Stocks: Who’s Leading The Race And Who’s Slipping?
August 20, 2024
Merck's wider drug moat and acquisition spree makes it a safer bet but VKTX can be the next LLY.
Via
Talk Markets
Biotech Bull Market: 3 Ways To Play It
August 20, 2024
Although we are in the later stages of this bull market a cut in interest rates by the Fed should help biotech as you have seen from the recent rally.
Via
Talk Markets
Topics
Economy
Exposures
Interest Rates
These 3 Healthcare Companies Had the Top-Selling Drugs Last Year
August 18, 2024
This list of top-selling drugs could look drastically different in a few years.
Via
The Motley Fool
Biden Administration Targets $6B Savings Through Medicare Drug Price Negotiations
August 15, 2024
Medicare drug price negotiations, enabled by the Inflation Reduction Act, are set to save the U.S. government $6 billion.
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
Medicare Slashes Merck, Novo, AstraZeneca Drug Prices Up To 79% In IRA Negotiations
August 15, 2024
The unveiled prices follow months of back-and-forth negotiation between the government and the companies.
Via
Investor's Business Daily
2 Dow Jones Stocks to Buy Hand Over Fist Right Now
August 15, 2024
Despite a possible recession, these two Dow Jones stocks are still a buy.
Via
The Motley Fool
Topics
Economy
Stocks
Exposures
Economy
US Equities
3 Pharmaceutical Stocks That Can Surge Higher Even if The Markets Correct
August 14, 2024
These are the pharmaceutical stocks to buy as they represent undervalued companies with a deep clinical pipeline that will support growth.
Via
InvestorPlace
< Previous
1
2
3
4
5
6
7
8
9
...
73
74
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.